GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (XCNQ:BETR) » Definitions » ROA %

BetterLife Pharma (XCNQ:BETR) ROA % : -171.43% (As of Oct. 2023)


View and export this data going back to 2017. Start your Free Trial

What is BetterLife Pharma ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. BetterLife Pharma's annualized Net Income for the quarter that ended in Oct. 2023 was C$-0.78 Mil. BetterLife Pharma's average Total Assets over the quarter that ended in Oct. 2023 was C$0.46 Mil. Therefore, BetterLife Pharma's annualized ROA % for the quarter that ended in Oct. 2023 was -171.43%.

The historical rank and industry rank for BetterLife Pharma's ROA % or its related term are showing as below:

XCNQ:BETR' s ROA % Range Over the Past 10 Years
Min: -31933.33   Med: -1210.62   Max: -13
Current: -706.7

During the past 13 years, BetterLife Pharma's highest ROA % was -13.00%. The lowest was -31933.33%. And the median was -1210.62%.

XCNQ:BETR's ROA % is ranked worse than
98.26% of 1551 companies
in the Biotechnology industry
Industry Median: -34.84 vs XCNQ:BETR: -706.70

BetterLife Pharma ROA % Historical Data

The historical data trend for BetterLife Pharma's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma ROA % Chart

BetterLife Pharma Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -171.72 -211.11 -755.97 -962.33 -1,458.90

BetterLife Pharma Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6,452.83 -1,421.47 -967.63 -726.56 -171.43

Competitive Comparison of BetterLife Pharma's ROA %

For the Biotechnology subindustry, BetterLife Pharma's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BetterLife Pharma's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's ROA % distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's ROA % falls into.



BetterLife Pharma ROA % Calculation

BetterLife Pharma's annualized ROA % for the fiscal year that ended in Jan. 2023 is calculated as:

ROA %=Net Income (A: Jan. 2023 )/( (Total Assets (A: Jan. 2022 )+Total Assets (A: Jan. 2023 ))/ count )
=-9.016/( (1.161+0.075)/ 2 )
=-9.016/0.618
=-1,458.90 %

BetterLife Pharma's annualized ROA % for the quarter that ended in Oct. 2023 is calculated as:

ROA %=Net Income (Q: Oct. 2023 )/( (Total Assets (Q: Jul. 2023 )+Total Assets (Q: Oct. 2023 ))/ count )
=-0.78/( (0.4+0.51)/ 2 )
=-0.78/0.455
=-171.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Oct. 2023) net income data. ROA % is displayed in the 30-year financial page.


BetterLife Pharma  (XCNQ:BETR) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Oct. 2023 )
=Net Income/Total Assets
=-0.78/0.455
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.78 / 0)*(0 / 0.455)
=Net Margin %*Asset Turnover
=N/A %*0
=-171.43 %

Note: The Net Income data used here is four times the quarterly (Oct. 2023) net income data. The Revenue data used here is four times the quarterly (Oct. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


BetterLife Pharma ROA % Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma (XCNQ:BETR) Business Description

Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.
Executives
Ahmad Doroudian Director, Senior Officer